TrialDiabetologia2016

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial.

Mark M Smits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.